<DOC>
	<DOCNO>NCT01074515</DOCNO>
	<brief_summary>The goal study look gene certain chemical body related depression chronic obstructive pulmonary disease .</brief_summary>
	<brief_title>Chronic Obstructive Pulmonary Disease ( COPD ) Activity : Serotonin Transporter ( SERT ) , Cytokines Depression ( CASCADE Study )</brief_title>
	<detailed_description>Depression highly prevalent among patient chronic obstructive pulmonary disease ( COPD ) associate adverse clinical outcome . The overall goal proposal examine impact inflammation genetic risk factor depression patient severe COPD , ass combine effect inflammation , genetics , depression change functional outcome . There increase evidence COPD associate systemic inflammation impact organ system . High level systemic inflammatory marker also link increase risk depression healthy chronically ill population . The neurotransmitter serotonin involve pathophysiology affective disorder regulate serotonin transporter ( SERT ) control reuptake serotonin brain synapsis . Recent study report SERT polymorphisms associate depression , suggest variant gene may important determine whether patient COPD develop depression course disease . The preliminary data link SERT polymorphisms depression data suggest relationship inflammation , depression COPD strongly argue large scale prospective study critically test relationship . Therefore , aim prospective study patient moderate severe COPD : 1 ) Examine relationship SERT polymorphism depression ; 2 ) Examine bi-directional longitudinal relationship marker systemic inflammation ( CRP , IL-1ra , IL-6 , IL-12 , TNF-α , IFN-γ ) depressive symptom COPD , explore role exacerbation SERT genotype relationship ; 3 ) Determine relationship depression , inflammation , SERT genotype decline functional outcome ( six minute walk test distance , physical activity measure accelerometer , dyspnea severity , health relate quality life ) COPD 2 year . Patients COPD GOLD Stages II-IV ( n=350 ) recruit two clinical site 30 month . Assessments baseline , year 1 year 2 include : blood sample genotyping ( 5-HTTLPR , STin2 VNTR , rs25331 ) cytokine assay ( CRP , IL-1ra , IL-6 , IL-12 , TNF-α , IFN-γ ) , spirometry , assessment depression , functional capacity ( six minute walk test ) , performance ( physical activity derive accelerometry ) , dyspnea , health relate quality life ( HRQL ) . We use advanced longitudinal statistical technique , structural equation model latent growth model , assess dynamic change depression , inflammation , functional status posit model process unfold time .</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<criteria>Diagnosis COPD confirm follow : 1 ) FEV1/FVC &lt; 70 % ; 2 ) Moderate severe disease GOLD criterion ( FEV1 &lt; 65 % ) ; 2 ) Age &gt; 40 year ; 3 ) A significant history current past cigarette smoking ( &gt; 10 packyears ) ; Stable disease acute exacerbation COPD past 4 week ; Ability speak , read write English Acute COPD exacerbation within past 4 week ( temp exclusion ) Chronic obstructive lung disorder unrelated COPD : asthma , bronchiectasis , cystic fibrosis Idiopathic Pulmonary Fibrosis Congestive Heart Failure Chronic renal failure require dialysis Primary pulmonary vascular disease Chronic inflammatory , infectious autoimmune disease , e.g . osteomyelitis , crohn 's disease rheumatoid arthritis Chronic liver disease Metastatic cancer Chronic antibiotic use ongoing infection Chronic oral prednisone use Moderate severe dementia Severe primary mental illness , e.g . schizophrenia , bipolar disease , severe obsessive compulsive disorder &lt; 2 year life expectancy History fainting spirometry</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>COPD</keyword>
	<keyword>Depression</keyword>
	<keyword>Inflammation</keyword>
	<keyword>Genetics</keyword>
	<keyword>Functioning</keyword>
	<keyword>Dyspnea</keyword>
	<keyword>Physical activity</keyword>
</DOC>